Order directing doctors to prescribe only generic medicines put on hold

The orders issued by the National Medical Commission (NMC) which had barred doctors from prescribing medicines other than generic drugs has been put on hold with immediate effect. The decision was made after the Indian Medical Association (IMA) and the Federation of Resident Doctors Association approached the Centre and Union Health Minister Mansukh Mandaviya.

The National Medical Commission’s Registered Medical Practitioner (Professional Conduct) Regulations, 2023, had made the prescription of generic drugs mandatory for doctors, along with other directives. The regulatory body had stated that since generic medicines are 30 to 80 per cent cheaper than branded drugs, this new rule would lower healthcare costs.

The NMC’s orders have been opposed by doctors ever since it was notified. The doctors argued that the quality control of generic medicines is weak in India and such rules will put patients at risk.

A Public Interest Litigation (PIL) was also filed in the Supreme Court seeking stringent disciplinary actions against registered medical practitioners who do not prescribe generic alternatives to branded names.

Related Posts

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

Pak-made illegal cosmetics recovered from Itwari shop

Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert